Axtria Secures $240 Million Investment from Kedaara Capital

September 23, 2025
Axtria and Kedaara Capital have completed a $240 million transaction, providing liquidity to employees and early investors.

Axtria and Kedaara Capital have announced the successful completion of a $240 million transaction, announced in a press release. This transaction is structured as a combination of secondary investment and company-sponsored buyback, providing liquidity to Axtria's current and former employees, as well as early investors.

The investment underscores Kedaara's commitment to high-quality businesses and highlights Axtria's role in the intersection of AI, innovation, and global life sciences transformation. Axtria, founded in 2010, supports 18 of the top 20 global pharmaceutical companies and over 100 firms across 75 countries with its AI-led solutions.

Axtria's platform portfolio includes Axtria InsightsMAx.ai, which offers over 30 ready-to-deploy agents, apps, and APIs to help life sciences companies transition from experimentation to scaled AI deployment. This investment marks one of the largest employee-centric liquidity events in the industry, reflecting Axtria's commitment to recognizing and rewarding its workforce.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

09/23
Judi Health Secures $400 Million to Expand AI-Powered Health Benefits Platform
09/23
DaltonTx Secures £4 Million to Advance AI Drug Discovery Platform
09/23
wexler.ai Secures $5.3M to Enhance Legal Fact-Checking
09/23
Kingsoft Cloud Plans Share Offering to Boost AI Business
09/23
Rocket.new Secures $15M to Expand AI-Powered App Development

More from: Life Sciences

09/23
SciBase Receives Initial Order for Clinical Study with Castle Biosciences
09/23
TegMine and Boehringer Ingelheim Collaborate on Cancer Antibody System
09/23
NextPlat's ClearMetrX 4.0 to Enhance Healthcare Analytics with AI
09/23
HCAP Partners Invests in Real Diagnostics for Growth Expansion
09/23
Myriad and SOPHiA GENETICS Collaborate on Liquid Biopsy Diagnostic

Subscribe to AI Funding Brief

AI Token Webinar

Market report

Superagency in the Workplace: Empowering People to Unlock AI’s Full Potential

This report explores the transformative potential of artificial intelligence in the workplace, emphasizing the readiness of employees versus the slower adaptation of leadership. It highlights the significant productivity growth potential AI offers, akin to historical technological shifts, and discusses the barriers to achieving AI maturity within organizations. The report also examines the role of leadership in steering companies towards effective AI integration and the need for strategic investments to harness AI's full capabilities.

Read more

You May Also Like